Skip to main content
  • Saved

Commented on 's Post

Real-World Patient Experience of CGRP-Targeting Therapy for Migraine: a Narrative Review - Current Pain and Headache Reports

Real-World Patient Experience of CGRP-Targeting Therapy for Migraine: a Narrative Review - Current Pain and Headache Reports

Source :

https://link.springer.com/article/10.1007/s11916-022-01077-z

Purpose of Review To summarize available calcitonin gene-related peptide (CGRP)-targeting therapies for migraine and discuss their use in real-world populations. Background CGRP has long been a topic of interest in migraine pathophysiology, with new therapies targeting CGRP since 2018 for both the preventive and acute treatment of migraine.


Recent findings and summary: Overall, studies reporting real-world patient experiences of CGRP-targeting therapies suggested meaningful effectiveness for migraine treatment with response rates comparable to the numbers reported in clinical trials. Furthermore, studies suggested benefit in patients with multiple prior unsuccessful treatment trials, medication overuse, and complex medical comorbidities. In some studies, adverse event rates have been notably higher than reported in clinical trials. Additional long-term data is needed to further evaluate sustained efficacy, predictors of treatment response, and adverse events.